News & Analysis on Clinical Trial Services & Contract Research And Development
Changes to manufacturing practices at Genzyme’s plant have led to further shortages of Fabrazyme (agalsidase beta), with production expected to remain below 30 per cent of demand until after June 30.
MedNet Solutions is introducing iMedNet, a pay-as-you-go web-based EDC platform to support collaboration and communication between clinical trial stakeholders.
SAFC Pharma is preparing for the shift towards cell culture-based vaccines, while still supplying and growing in the traditional sector, to ensure it can grow in coming years, according to a company director.
Lek has opened a 430m² modified protein manufacturing facility in Slovenia to produce epoetin alfa drug substance for use in the biosimilars marketed by its parent company, Sandoz.
Kendle posted a 37 per cent drop in operating income in 2009 and will lay off employees this quarter in response to the market’s “continued volatility” and late stage cancellations.